Epstein-Barr virus and human hepatocellular carcinoma

Cancer Letters

Volumn 192, Issue 1, 2003, Pages 49-57

  Akhter, Shamim ^a   Liu, Huifeng ^a   Prabhu, Ramesh ^a   DeLucca, Cynthia ^a   Bastian, Frank ^a   Garry, Robert F ^b   Schwartz, Myron ^c   Thung, Swan N ^c   Dash, Srikanta ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinogenesis; Epstein Barr virus; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

BETA GLOBULIN; DNA; NUCLEIC ACID; PARAFFIN; PRIMER RNA;

5' UNTRANSLATED REGION; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; EPSTEIN BARR VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RNA ISOLATION; SOUTHERN BLOTTING; VIRUS DETECTION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4;

EID: 0037456681     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00695-X     Document Type: Article

References (47)

1. Koike K., Moriya K., Kimura S. Role of hepatitis C virus in the development of hepatocellular carcinoma: Transgenic approach to viral hepatocarcinogenesis. J. Gastroenterol. Hepatol. 17:2002;394-400.
2. Koike K., Tsutsumi T., Fujie H., Shintani Y., Moriya K. Molecular mechanism of viral hepatocarcinogenesis. Oncology. 62:2002;29-37.
3. Shimotohno K. Hepatitis C virus and its pathogenesis. Semin. Cancer Biol. 10:2000;233-240.
4. Levy L., Renard C.A., Wei Y., Buendia M.A. Genetic alterations and oncogenic pathways in hepatocellular carcinoma. Ann. N.Y. Acad. Sci. 963:2002;21-36.
5. El-Serag H.B. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 5:2001;87-107.
6. Seeff L.B. Natural history of hepatitis C. Am. J. Med. 107:1999;10S-15S.
7. Ramadori G., Meier V. Hepatitis C virus infection: 10 years after the discovery of the virus. Eur. J. Gastroenterol. Hepatol. 13:2001;465-471.
8. Jeffers L. Hepatocellular carcinoma: an emerging problem with hepatitis C. J. Natl. Med. Assoc. 92:2000;369-371.
9. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. New Engl. J. Med. 340:1999;745-750.
10. Yu M.C., Yuan J.M., Govindarajan S., Ross R.K. Epidemiology of hepatocellular carcinoma. Can. J. Gastroenterol. 14:2000;703-709.
11. Arbuthnot P., Kew M. Hepatitis B virus and hepatocellular carcinoma. Int. J. Exp. Pathol. 82:2001;77-86.
12. Imperial J.C. Natural history of chronic hepatitis B and C. J. Gastroenterol Hepatol. 14:1999;S1-S5.
13. Beasley R.P., Hwang L.Y., Lin C.C., Chen C.S. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet. 2:1981;1129-1133.
14. Idilman R., De Maria N., Colantoni A., Van Thiel D.H. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J. Viral. Hepat. 5:1998;285-299.
15. Koike K., Moriya K., Lino S., Yotsuyanagi H., Endo Y., Miyamura T., Hurokawa K. High level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology. 19:1994;810-819.
16. Haruna Y., Hayashi N., Kamada T., Hytiroglou P., Thung S.N., Greber M.A. Expression of hepatitis C virus in hepatocellular carcinoma. Cancer. 73:1994;2253-2258.
17. Okuda K. Hepatocellular carcinoma. J. Hepatol. 32:2002;225-237.
18. Zoulim F., Saputelli J., Seeger C. Woodchuk hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68:1994;2026-2030.
19. Avantaggiati M.L., Balsano C., Natoli G., De Marzio E., Will H., El-Fassi E., et al. The hepatitis B virus X protein transactivation of c-fos and c-myc protooncogenes is mediated by multiple transcription factors. Arch. Virol. 4:1992;57-61.
20. Kwee L., Lucito R., Aufiero B., Schneider R.J. Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate Class II and Class III promoters. Virology. 66:1992;4382-4389.
21. Maguire H.F., Hoeffler J.P., Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science. 252:1991;842-844.
22. Kekule A.S., Lauer U., Meyer M., Caselmann W.H., Hofchneider P.H., Koshy R. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature. 343:1990;457-461.
23. Becker S.A., Lee T.-H., Butel J.S., Slagle B.L. Hepatitis B virus X protein interferes with cellular DNA repair. J. Virol. 72:1998;266-272.
24. Sugawara Y., Makuuchi M., Kato N., Shimotohno K., Takada K. Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen. EMBO J. 18:1999;5755-5760.
25. Sugawara Y., Makuuchi M., Takada K. Detection of Epstein-Barr virus DNA in hepatocellular carcinoma tissues from hepatitis C positive patients. Scand. J. Gastroenterol. 35:2000;981-984.
26. Gottschalk S., Heslop H.E., Roon C.M. Treatment of Epstein-Barr virus associated malignancies with specific T cells. Adv. Cancer Res. 84:2002;175-201.
27. Pagano J.S. Epstein-Barr virus: the first human tumor virus and its role in cancer. Proc. Assoc. Am. Phys. 111:1999;573-580.
28. Fukayama M., Chong J.M., Kaizaki Y. Epstein-Barr virus and gastric carcinoma. Gastric Cancer. 1:1998;104-114.
29. Giannoudis A., Ergazaki M., Segas J., Giotakis J., Adampoulos G., Gorgoulis V., Spandidos D.A. Detection of Epstein-Barr virus and human papillomavirus in nasopharyngeal carcinoma by the polymerase chain reaction technique. Cancer Lett. 89:1995;177-181.
30. Young L.S., Rowe M. Epstein-Barr virus, lymphomas and Hodgkin's disease. Semin. Cancer Biol. 3:1992;273-284.
31. Pallaesen G., Hamilton-Dutoit S.J., Rowe M., Young L.S. Expression of Epstein-Barr virus latent proteins in tumor cells of Hodgkin's disease. Lancet. 337:1991;320-322.
32. Fahraeus R., Rymo L., Rhim J.S., Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature. 345:1990;447-449.
33. Bonnet D.M., Arbach H., Takada H., Joab I. Association of the Epstein-Barr virus with breast cancer: in vivo and in vitro studies. Breast Cancer Res. 3:2001;13.
34. Labrecque L.G., Barnes D.M., Fentiman I.S., Griffin B.E. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 55:1995;139-145.
35. Chen M.L., Shieh Y.S.C., Shim K.S., Gerber M.A. Comparative studies on the detection of Hepatitis B virus DNA in frozen and paraffin sections by the polymerase chain reaction. Mod. Pathol. 4:1991;555-558.
36. Aykol G., Dash S., Shieh Y.S., Malter J.S., Gerber M.A. Detection of hepatitis C virus sequences by polymerase chain reaction in fixed liver tissue. Mod. Pathol. 5:1992;501-504.
37. Lampertico P., Malter J.S., Colombo M., Gerber M.A. Detection of hepatitis B virus DNA in formalin-fixed, paraffin-embedded liver tissue by the polymerase chain reaction. Am. J. Pathol. 137:1990;253-258.
38. Deacon E.M., Pallesen G., Niedobitek G., Crocker J., Brooks L., Rickinson A.B., et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 177:1993;339-349.
39. Thankamini V., Kumari T.V., Vasudevan D.M. Papilloma virus in cervical carcinoma: detection of viral antigen in cancer cells. J. Exp. Pathol. 6:1992;41-53.
40. Sugawara Y., Mizugaki Y., Uchida T., Torri T., Imai S., Makuuchi M., Takada K. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology. 256:1999;196-202.
41. Chu P.G., Chen Y.Y., Chen W.G., Weiss L.M. No direct role for Epstein-Barr virus in American hepatocellular carcinoma. Am. J. Pathol. 159:2001;1287-1292.
42. Gerber M.A., Shieh Y.S.C., Shim K.S., Thung S.N., Demetris A.J., Schwartz M., Aykol G., Dash S. Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am. J. Pathol. 141:1992;1271-1277.
43. Lee J.H., Ku J.L., Park Y.J., Lee K.U., Kim W.H., Park J.G. Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA. World J. Gastroenterol. 5:1999;289-295.
44. Han H.J., Jung E.Y., Lee W.J., Jang K.L. Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein. FEBS Lett. 518:2002;169-172.
45. Li J., Xu Z., Zheng Y., Johnson D.L., Ou J.H. Regulation of hepatocyte nuclear factor1 activity by wild-type and mutant hepatitis B virus X proteins. J. Virol. 76:2002;5875-5881.
46. Lan K.H., Sheu M.L., Hwang S.J., Yen S.H., Chen S.Y., Wu J.C., Wang Y.J., Kato N., Omata M., Chang F.Y., Lee S.D. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene. 21:2002;4801-4811.
47. Majumder M., Ghosh A.K., Steele R., Zhou X.Y., Philips N.J., Ray R., Ray R.B. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology. 294:2002;94-105.